Robert Wolff
- Health Informatics top 0.2%
- Pharmacology top 0.5%
- Toxicology top 1%
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 14
-
- Meta-analysis and systematic reviews 13
-
- Brain Metastases and Treatment 12
- Lung Cancer Treatments and Mutations 9
-
- Health Systems, Economic Evaluations, Quality of Life 11
-
- Glioma Diagnosis and Treatment 10
-
- Pancreatic and Hepatic Oncology Research 8
-
- Meningioma and schwannoma management 6
- Co-authors
- Jos KleijnenPenny WhitingSusan MallettKarel G.M. MoonsRichard D RileyGary S. CollinsJohannes B. ReitsmaKate Misso
- Journals
- Cochrane Database of Systematic Reviews (15 papers)PharmacoEconomics (10 papers)Acta Neurochirurgica (4 papers)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
Robert Wolff
93 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Health Informatics 302
- Pharmacology 1.5k
- Toxicology 179
- Hepatology 366
- Statistics, Probability and Uncertainty 285
Countries citing papers authored by Robert Wolff
This map shows the geographic impact of Robert Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wolff more than expected).
Fields of papers citing papers by Robert Wolff
This network shows the impact of papers produced by Robert Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wolff. The network helps show where Robert Wolff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Wolff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2020 | 10 | |
| 9 | 2020 | 5 | |
| 10 | 2017 | 5 | |
| 11 | Cannabinoids for Medical Usebreakdown → | 2015 | 1492 |
| 12 | 2014 | 38 | |
| 13 | 2012 | 48 | |
| 14 | 2011 | 9 | |
| 15 | 2011 | 25 | |
| 16 | 2011 | 3 | |
| 17 | 2010 | 45 | |
| 18 | 2009 | 3 | |
| 19 | 2004 | 17 | |
| 20 | 2004 | 12 |
About Robert Wolff
Robert Wolff is a scholar working on Medical Terminology, Statistics, Probability and Uncertainty and Hepatology, having authored 96 papers that have together received 6.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Meta-analysis and systematic reviews (13 papers), Brain Metastases and Treatment (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers), Glioma Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Meningioma and schwannoma management (6 papers). The work is most often cited by research in Health Informatics (302 citations), Pharmacology (1.5k citations) and Toxicology (179 citations). Robert Wolff has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Jos Kleijnen, Penny Whiting, Susan Mallett, Karel G.M. Moons, Richard D Riley, Gary S. Collins, Johannes B. Reitsma, Kate Misso, Adrían V. Hernández and Steven Duffy. Their work appears in journals such as Cochrane Database of Systematic Reviews, PharmacoEconomics, Acta Neurochirurgica, Journal of neurosurgery and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.